Bafna Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 406.78 million compared to INR 219.61 million a year ago. Revenue was INR 408.37 million compared to INR 226.03 million a year ago. Net income was INR 24.84 million compared to INR 16.09 million a year ago. Basic earnings per share from continuing operations was INR 1.05 compared to INR 0.68 a year ago. Diluted earnings per share from continuing operations was INR 1.05 compared to INR 0.68 a year ago.
For the six months, sales was INR 826.25 million compared to INR 388.88 million a year ago. Revenue was INR 846.53 million compared to INR 408.31 million a year ago. Net income was INR 88.35 million compared to INR 29.71 million a year ago. Basic earnings per share from continuing operations was INR 3.73 compared to INR 1.25 a year ago. Diluted earnings per share from continuing operations was INR 3.73 compared to INR 1.25 a year ago.